Vitiligo: vizsgálatok itt: Argentína
4 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
- Where
- Buenos Aires, CABA, Rosario, San Miguel de Tucumán
- Életkor
- 18 év to 99 év
- People
- 210 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07431177 · EU 2025-522301-37-00 - 3. fázisTaking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Buenos Aires, Mar del Plata, Rosario, San Miguel de Tucumán
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
- Where
- Buenos Aires, Derqui, Pilar, Mar del Plata, San Miguel de Tucumán
- Életkor
- 6 év to 11 év
- People
- 250 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06804811 · EU 2024-513171-41-00 - No phaseTaking peopleA Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aire
- Életkor
- 12 év and over
- People
- 2795 worldwide
- Run by
- AbbVie
See details and how to joinNCT07136467